Trial intelligence / Profile preview

Responsiveness of EQS to Vardenafil in ED

NCT00665340Phase 4Completed

Sponsor
Bayer
Start
Jul 2004
Primary completion
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vardenafil in erectile dysfunction (ED), sponsored by Bayer. Started Jul 2004; status: completed.

02

Drugs

vardenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00665340.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00665340.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call